GT Biopharma Inc (GTBP)
3.01
+0.05
(+1.69%)
USD |
NASDAQ |
Jun 25, 16:00
3.11
+0.10
(+3.32%)
After-Hours: 20:00
GT Biopharma EPS Diluted (Annual): -5.584 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.584 |
| December 31, 2022 | -19.46 |
| December 31, 2021 | -61.80 |
| December 31, 2020 | -193.50 |
| December 31, 2019 | -342.48 |
| December 31, 2018 | -2631.58 |
| December 31, 2017 | -4385.96 |
| December 31, 2016 | 47882.35 |
| December 31, 2015 | -1.429M |
| December 31, 2014 | -1.566M |
| December 31, 2013 | -35785.71 |
| December 31, 2012 | -397769.2 |
| December 31, 2011 | -528571.4 |
| December 31, 2010 | -1.006M |
| December 31, 2009 | -2.246M |
| December 31, 2008 | -5.006M |
| December 31, 2007 | 471000.0 |
| December 31, 2006 | -4.94M |
| December 31, 2005 | -3.109M |
| December 31, 2004 | -2.698M |
| December 31, 2003 |
| Date | Value |
|---|---|
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | |
| December 31, 1998 | |
| December 31, 1997 | -5.20M |
| December 31, 1996 | -89.90M |
| December 31, 1995 | -8.90M |
| December 31, 1994 | -168.32M |
| December 31, 1993 | -57.38M |
| December 31, 1992 | -13.39M |
| December 31, 1991 | -7.651M |
| December 31, 1990 | 32.52M |
| December 31, 1989 | 28.69M |
| December 31, 1988 | 5.738M |
| December 31, 1987 | 11.48M |
| December 31, 1986 | -15.30M |
| December 31, 1985 | -13.39M |
| December 31, 1984 | 7.651M |
| February 29, 1984 | 11.48M |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-342.48
Minimum
2019
-5.584
Maximum
2023
-124.57
Average
-61.80
Median
2021
EPS Diluted (Annual) Benchmarks
| Cutera Inc | -8.19 |
| Oragenics Inc | -9.18 |
| Outlook Therapeutics Inc | -4.80 |
| 180 Life Sciences Corp | -52.59 |
| Scorpius Holdings Inc | -1.74 |